Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids.

The Journal of Steroid Biochemistry and Molecular Biology
Luciana Rocha ViegasAdali Pecci

Abstract

Physiological cell turnover is under the control of a sharp and dynamic balance of different homeostatic mechanisms such as the equilibrium between cell proliferation and cell death. These mechanisms play an important role in maintaining normal tissue function and architecture. It is well known that apoptosis is the prevalent mode of physiological cell loss in most tissues. Steroid hormones like glucocorticoids have been identified as key signals controlling cell turnover by modulating programmed cell death in a tissue- and cell-specific manner. In this sense, several reports have demonstrated that glucocorticoids are able to induce apoptosis in cells of the hematopoietic system such as monocytes, macrophages, and T lymphocytes. In contrast, they protect against apoptotic signals evoked by cytokines, cAMP, tumor suppressors, in glandular cells such as the mammary gland epithelia, endometrium, hepatocytes, ovarian follicular cells, and fibroblasts. Although several studies have provided significant information on hormone-dependent apoptosis in an specific tissue, a clearly defined pathway that mediates cell death in response to glucocorticoids in different cell types is still misunderstood. The scope of this review is held to th...Continue Reading

References

May 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M YoshidaT Beppu
Jun 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L A Caron-LeslieJ A Cidlowski
Jun 15, 1997·The Journal of Clinical Investigation·Y FujioT Kishimoto
Jan 7, 1998·The Journal of Cell Biology·K G WolterR J Youle
Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YamamotoY Komatsu
Aug 28, 1998·Science·D R Green, J C Reed
Sep 12, 1998·Science·J M Adams, S Cory
Sep 30, 1998·Cell·D R Green
Oct 24, 1998·Journal of Reproductive Immunology·S G Hillier, M Tetsuka
Feb 2, 1999·The Journal of Experimental Medicine·C L MokH J Brady
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Feb 23, 2000·Neuroscience·A M GormanS Ceccatelli
Apr 26, 2000·British Journal of Pharmacology·U K MessmerJ Pfeilschifter
Nov 21, 2000·Current Opinion in Oncology·J M GradL H Boise
Feb 15, 2001·Cell Death and Differentiation·Y Tsujimoto, S Shimizu
Jun 1, 2002·Molecular and Cellular Endocrinology·Abraham Amsterdam, Ravid Sasson
Jul 30, 2002·Molecular Endocrinology·Matthew R Yudt, John A Cidlowski
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Feb 1, 2003·Cancer Cell·John C Reed
Feb 21, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas MundStefan Grimm
Mar 15, 2003·The Journal of Biological Chemistry·Duncan M GascoyneMaria d M Vivanco
Dec 18, 2003·The Journal of Biological Chemistry·Luciana Rocha ViegasAdalí Pecci
Mar 24, 2004·Genes & Development·François TroncheGünther Schütz
Jul 1, 2005·Journal of the American Society of Nephrology : JASN·Takehiko WadaStuart J Shankland
Sep 20, 2005·Critical Reviews in Immunology·Sandrine LépineFrançoise Giraud
Apr 21, 2006·The Journal of Biological Chemistry·Matthew P SaelzlerMark K Abe
Sep 9, 2006·The Journal of Biological Chemistry·Luciana Rocha-ViegasAdali Pecci

❮ Previous
Next ❯

Citations

May 8, 2009·Apoptosis : an International Journal on Programmed Cell Death·Christian PlonerReinhard Kofler
May 18, 2011·Breast Cancer Research : BCR·Lilia AntonovaChristopher R Mueller
Jun 9, 2010·Therapeutics and Clinical Risk Management·Ege Can Serefoglu, Zafer Tandogdu
Feb 18, 2011·Leukemia & Lymphoma·Elena KanDaniel Benharroch
Sep 14, 2010·The International Journal of Biochemistry & Cell Biology·Alexander V Sirotkin
Jul 6, 2010·European Journal of Pharmacology·Alexander V SirotkinAlexander V Makarevich
Sep 23, 2008·Trends in Endocrinology and Metabolism : TEM·Katherine L Gross, John A Cidlowski
Aug 19, 2010·Journal of Cellular Physiology·Alexander V SirotkinRoland Grosmann
Feb 24, 2009·Brain Research·David Xu JinJianxin Bao
Nov 15, 2011·Biochemical and Biophysical Research Communications·Xiao-dong HeFumikazu Okajima
Oct 14, 2017·Endocrinology·Shannon Whirledge, Donald B DeFranco
Aug 10, 2018·Connective Tissue Research·Juan Pablo RamírezRodolfo Paredes
Oct 15, 2013·Anatomia, histologia, embryologia·A BalaziP Chrenek
Jun 16, 2009·Cell Biology International·Yuko Nakamura-LópezBeatriz Gómez-García
Aug 11, 2009·Journal of Basic and Clinical Physiology and Pharmacology·Gordana BjelakovićJelena Basić
Jul 27, 2021·Frontiers in Cardiovascular Medicine·Lujin WuDao Wen Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis